Guardant Health, Inc. logo

Guardant Health, Inc. (GH)

$31.93

Guardant Health, Inc. (GH) Share Price Forecast
Currently 30 wall-street analysts regularly analyze the financials of Guardant Health, Inc. on a frequent basis to provide recommendations along with target share price. 30 analysts offering 12-month price forecasts for Guardant Health, Inc. (GH) have a share price target of $37.42. This median of share price forecast represents a 17.19% upside from the latest price of $31.93 as on 26.07.24.

Guardant Health, Inc. (GH) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Guardant Health, Inc. (GH) share price will touch around $37.42 in next 12-months.
Guardant Health, Inc. (GH) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Guardant Health, Inc.'s share price and its median forecast price. As on 26.07.24, the difference is -24.48%

Guardant Health, Inc. (GH): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Guardant Health, Inc. (GH) Share Price : Analyst Recommendation
Based on 30 analysts tracking and researching Guardant Health, Inc. (GH) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
14
14
14
Outperform
11
11
11
Hold
5
5
5
Underperform
0
0
0
Sell
0
0
0
Guardant Health, Inc. (GH) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Guardant Health, Inc. (GH) is $37.42, offered by 30 analysts offering 12-month price forecasts.

Guardant Health, Inc. (GH) has a maximum of 0.17 upside potential, based on 30 analysts offering 12-month price forecasts.

Based on 30 analysts tracking and researching Guardant Health, Inc. (GH), 83.33% have a buy recommendation. Remaining 16.67% have either sell or hold recommendations.

The latest share price of Guardant Health, Inc. (GH) is $31.93 as of 26/07/2024.

25 of total 30 analysts offering stock ratings for Guardant Health, Inc. GH have recommended buy rating.